Coya Therapeutics, Inc. (COYA) — DEF 14A Filings
All DEF 14A filings from Coya Therapeutics, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Coya Therapeutics Files 2025 Proxy Statement
— May 16, 2025 Risk: low
Coya Therapeutics, Inc. filed its definitive proxy statement (DEF 14A) on May 16, 2025, for its annual meeting scheduled for June 26, 2025. The filing covers th -
Coya Therapeutics, Inc. Announces Annual Meeting of Stockholders on May 8, 2024
— Mar 28, 2024 Risk: low
Coya Therapeutics, Inc. (COYA) filed a Proxy Statement (DEF 14A) with the SEC on March 28, 2024. Coya Therapeutics, Inc. will hold its Annual Meeting of Stockho
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX